Rallybio to Present at the 2023 Wedbush PacGrow Healthcare Conference
02 8월 2023 - 9:00PM
Business Wire
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage
biotechnology company committed to identifying and accelerating the
development of life-transforming therapies for patients with severe
and rare diseases, today announced that Steve Uden, M.D., Chief
Executive Officer of Rallybio, will participate in a panel
discussion, “When You’re One in a Million – Orphan Drug
Reimbursement/Regulation,” at the 2023 Wedbush PacGrow Healthcare
Conference on August 9, 2023 at 11:00 a.m. ET in New York, NY.
About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology
company with a mission to develop and commercialize
life-transforming therapies for patients with severe and rare
diseases. Rallybio has built a broad pipeline of promising product
candidates aimed at addressing diseases with unmet medical need in
areas of maternal fetal health, complement dysregulation,
hematology, and metabolic disorders. The Company has two clinical
stage programs: RLYB212, an anti-HPA-1a antibody for the prevention
of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and
RLYB116, an inhibitor of complement component 5 (C5), with the
potential to treat several diseases of complement dysregulation, as
well as additional programs in preclinical development.
Rallybio is headquartered in New Haven, Connecticut with an
additional facility at the University of Connecticut’s Technology
Incubation Program in Farmington, Connecticut. For more
information, please visit www.rallybio.com and follow us on
LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230726873939/en/
Investor: Ami Bavishi Head of Investor Relations and
Communications 475-47-RALLY (Ext. 282) abavishi@rallybio.com
Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com
Media: Tara DiMilia 908-369-7168
Tara.dimilia@tmstrat.com
Rallybio (NASDAQ:RLYB)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Rallybio (NASDAQ:RLYB)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024